This study extends previous [18F]-fallypride-based investigations of dAMPH effects by involving patients with known neuroanatomical defects (e.g., PD) and linking dAMPH-induced mood and behavioral effects to changes in D2-R availability in both striatal and extra-striatal regions. This evidence concerns the gene DRD2 and Parkinson disease.